15807716

Source:http://linkedlifedata.com/resource/pubmed/id/15807716

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0039225, umls-concept:C0087111, umls-concept:C0376409, umls-concept:C0521362, umls-concept:C0524527, umls-concept:C0525005, umls-concept:C1707455
pubmed:issue	2
pubmed:dateCreated	2005-4-5
pubmed:abstractText	To compare gastrointestinal (GI) tolerability and patient preference for the new 625 mg formulation of nelfinavir (NFV) and the marketed 250 mg tablets (Viracept) in HIV-1-infected patients.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/100897392
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/HIV Protease Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Nelfinavir, http://linkedlifedata.com/resource/pubmed/chemical/Tablets
pubmed:status	MEDLINE
pubmed:month	Mar
pubmed:issn	1464-2662
pubmed:author	pubmed-author:ArastehKK, pubmed-author:ArtigasJ GJG, pubmed-author:ClotetBB, pubmed-author:DaniseAA, pubmed-author:ForemanRR, pubmed-author:Gonzalez-GarciaJJ, pubmed-author:HorbanAA, pubmed-author:JohnsonMM, pubmed-author:LandmanRR, pubmed-author:Nieto-CisnerosLL, pubmed-author:ProllSS, pubmed-author:SmithPP, pubmed-author:SnowdenWW
pubmed:issnType	Print
pubmed:volume	6
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	107-13
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:15807716-CD4 Lymphocyte Count, pubmed-meshheading:15807716-Diarrhea, pubmed-meshheading:15807716-Drug Administration Schedule, pubmed-meshheading:15807716-HIV Infections, pubmed-meshheading:15807716-HIV Protease Inhibitors, pubmed-meshheading:15807716-HIV-1, pubmed-meshheading:15807716-Humans, pubmed-meshheading:15807716-Nelfinavir, pubmed-meshheading:15807716-Patient Satisfaction, pubmed-meshheading:15807716-Tablets, pubmed-meshheading:15807716-Viral Load
pubmed:year	2005
pubmed:articleTitle	Comparison of gastrointestinal tolerability and patient preference for treatment with the 625 mg and 250 mg nelfinavir tablet formulations.
pubmed:affiliation	Royal Free Hospital, London, UK. margaret.johnson@royalfree.nhs.uk
pubmed:publicationType	Journal Article, Clinical Trial, Comparative Study, Controlled Clinical Trial, Research Support, Non-U.S. Gov't, Multicenter Study